A systematic review of validated methods for identifying atrial fibrillation using administrative data

The objectives of this study were to characterize the validity of algorithms to identify AF from electronic health data through a systematic review of the literature and to identify gaps needing further research.

[1]  G. Naccarelli,et al.  Increasing prevalence of atrial fibrillation and flutter in the United States. , 2009, The American journal of cardiology.

[2]  D. Berlowitz,et al.  Identifying Hypertension-Related Comorbidities From Administrative Data: What's the Optimal Approach? , 2004, American journal of medical quality : the official journal of the American College of Medical Quality.

[3]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[4]  D. Singer,et al.  Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study , 1999, Annals of Internal Medicine.

[5]  Elsayed Z Soliman,et al.  Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. , 2009, American heart journal.

[6]  H. Krumholz,et al.  Warfarin use among patients with atrial fibrillation. , 1997, Stroke.

[7]  B. Psaty,et al.  Newly detected atrial fibrillation and compliance with antithrombotic guidelines. , 2007, Archives of internal medicine.

[8]  B. Gage,et al.  Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation. , 1999, American heart journal.

[9]  Silvia G. Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .

[10]  L H Kuller,et al.  Incidence of and risk factors for atrial fibrillation in older adults. , 1997, Circulation.

[11]  R. Cebul,et al.  Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation , 1996, Journal of General Internal Medicine.

[12]  D. Singer,et al.  Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. , 2000, Circulation.

[13]  E. Ellerbeck,et al.  Combined Anticoagulant–Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients , 2004, Stroke.

[14]  S. Gaehde,et al.  Anticoagulant Use for Atrial Fibrillation in the Elderly , 2004, Journal of the American Geriatrics Society.

[15]  P A Wolf,et al.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.

[16]  D. Einstadter,et al.  Atrial fibrillation as a risk factor for stroke: a retrospective cohort study of hospitalized Medicare beneficiaries. , 1998, American journal of public health.

[17]  M. Rich,et al.  Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation. , 2000, Stroke.

[18]  J. Whittle,et al.  Is warfarin underused in the treatment of elderly persons with atrial fibrillation? , 1997, Archives of internal medicine.

[19]  Jacob Cohen.  A Coefficient of Agreement for Nominal Scales , 1960 .

[20]  T. Lumley,et al.  Risk of new-onset atrial fibrillation in relation to body mass index. , 2006, Archives of internal medicine.

[21]  Wansu Chen,et al.  Racial/Ethnic Differences in Ischemic Stroke Rates and the Efficacy of Warfarin Among Patients With Atrial Fibrillation , 2008, Stroke.

[22]  B. Griffith,et al.  Atrial fibrillation: prevalence after minimally invasive direct and standard coronary artery bypass. , 2001, The Annals of thoracic surgery.